SCM
Sio Capital Management Portfolio holdings
AUM
$249M
1-Year Return
117.71%
This Quarter Return
+15.17%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$329M
AUM Growth
+$48.2M
(+17%)
Cap. Flow
+$21.5M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
47.62%
Holding
92
New
27
Increased
14
Reduced
15
Closed
20
Top Buys
| 1 |
Merck
MRK
|
$15.4M |
| 2 |
Gilead Sciences
GILD
|
$12.1M |
| 3 |
GSK
GSK
|
$9.62M |
| 4 |
Sanofi
SNY
|
$8.58M |
| 5 |
Medtronic
MDT
|
$7.52M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$18.6M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$9.91M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$7.52M |
| 4 |
Avantor
AVTR
|
$6.99M |
| 5 |
InMode
INMD
|
$5.79M |
Sector Composition
| 1 | Healthcare | 92.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
26
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $4.09M | 0.97% |
37,781
-13,500
| -26% | -$1.46M |
|
|
ARNA
27
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $4.06M | 0.97% |
89,357
+45,500
| +104% | +$2.07M |
|
28
Integer Holdings
ITGR
$3.7B
| $3.59M | 0.86% |
44,679
-5,917
| -12% | -$476K |
|
29
Esperion Therapeutics
ESPR
$492M
| $3.38M | 0.8% |
+56,658
| New | +$3.38M |
|
|
SYNH
30
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $3.17M | 0.76% |
53,297
| – | – |
|
|
SYRS
31
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $3.1M | 0.74% |
+44,853
| New | +$3.1M |
|
|
TRIL
32
DELISTED
Trillium Therapeutics Inc.
TRIL
| $2.83M | 0.68% |
+2,751,186
| New | +$2.83M |
|
|
AFMD
33
DELISTED
Affimed
AFMD
| $2.79M | 0.66% |
+101,820
| New | +$2.79M |
|
34
Harrow
HROW
$1.37B
| $2.68M | 0.64% |
344,940
+6,326
| +2% | +$49.2K |
|
|
PFNX
35
DELISTED
Pfenex Inc.
PFNX
| $2.55M | 0.61% |
232,626
+39,018
| +20% | +$428K |
|
36
Larimar Therapeutics
LRMR
$324M
| $2.53M | 0.6% |
+190,264
| New | +$2.53M |
|
|
UROV
37
DELISTED
Urovant Sciences Ltd.
UROV
| $2.49M | 0.59% |
160,442
-28,400
| -15% | -$440K |
|
38
Medpace
MEDP
$13.4B
| $2.24M | 0.53% |
26,601
-24,800
| -48% | -$2.08M |
|
|
ASLN
39
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $2.07M | 0.49% |
+25,449
| New | +$2.07M |
|
|
RDUS
40
DELISTED
Radius Health, Inc.
RDUS
| $2.02M | 0.48% |
+100,000
| New | +$2.02M |
|
41
Bionano Genomics
BNGO
$17.6M
| $1.5M | 0.36% |
2,018
-381
| -16% | -$283K |
|
|
RVNC
42
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.42M | 0.34% |
87,700
-217,964
| -71% | -$3.54M |
|
43
Halozyme
HALO
$8.69B
| $1.4M | 0.33% |
79,067
-241,306
| -75% | -$4.28M |
|
44
Gyre Therapeutics
GYRE
$704M
| $1.39M | 0.33% |
27,290
-3,334
| -11% | -$170K |
|
|
ARAV
45
DELISTED
Aravive, Inc. Common Stock
ARAV
| $1.34M | 0.32% |
+98,201
| New | +$1.34M |
|
|
BCEL
46
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $1.32M | 0.31% |
+85,312
| New | +$1.32M |
|
47
Exicure
XCUR
$32.3M
| $1.3M | 0.31% |
3,019
-1,479
| -33% | -$634K |
|
48
Arvinas
ARVN
$557M
| $1.24M | 0.29% |
+30,052
| New | +$1.24M |
|
49
Progyny
PGNY
$2.02B
| $1.23M | 0.29% |
+44,910
| New | +$1.23M |
|
50
Opko Health
OPK
$1.09B
| $1.18M | 0.28% |
+805,311
| New | +$1.18M |
|